Mike Kelly bought Bristol-Myers Squibb Company (NYSE: BMY)
Mike Kelly (R-PA), a U.S. Representative, has disclosed 3 trades in Bristol-Myers Squibb Company (BMY) since 2018, 1 purchase and 2 sales, worth an estimated $49K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Mike Kelly bought $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on September 17, 2018. Since that trade, BMY is up +23.82% against the S&P 500 up +192.74%, an outperformance of -168.92%.
Across these filings, Mike Kelly has been a net seller of BMY (a buy-to-sell ratio of 0.50). The most recent disclosed BMY transaction shown was dated May 7, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Mike Kelly's BMY trades vs the price
BMY is up +23.82% since Mike Kelly bought on September 17, 2018, versus +192.74% for the S&P 500.
Performance since this trade
All Mike Kelly BMY trades
Mike Kelly & BMY trading FAQ
Is it legal for Mike Kelly to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mike Kelly buy BMY?
Mike Kelly disclosed a purchase of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on September 17, 2018, according to public STOCK Act filings.
How has BMY performed since Mike Kelly's trade?
Since Mike Kelly bought BMY on September 17, 2018, the stock is up +23.82%, versus +192.74% for the S&P 500 over the same period, an outperformance of -168.92%.
How many times has Mike Kelly traded BMY?
Mike Kelly has disclosed 3 BMY trades since 2018 (1 purchase and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Mike Kelly's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyMike Kelly's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.